These drugs fall within two categories: human GLP-1 backbone agents (that is, albiglutide, dulaglutide, liraglutide and semaglutide) and exendin-4 backbone agents (that is, exenatide, lixisenatide and tirzepatidethe latter activating both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors) 1
Before choosing a treatment, its important to know what each treatment has been proven to do, its safety record, the support youll have access to and how it might fit into your own goals, lifestyle and weight-loss plans
It is the plan that helps the patient lose weight, preserve muscle, improve metabolic markers, and function well enough to build lasting habits
Light to moderate exercise is generally safe and may actually help prevent cramping